Premier Biomedical, Inc. (OTCMKTS:BIEI) Short Interest Down 15.9% in May

Premier Biomedical, Inc. (OTCMKTS:BIEI) saw a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 160,400 shares, a decrease of 15.9% from the April 30th total of 190,800 shares. Based on an average daily volume of 4,289,000 shares, the short-interest ratio is presently 0.0 days.

Premier Biomedical Stock Performance

Shares of BIEI stock opened at $0.00 on Tuesday. Premier Biomedical has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.

About Premier Biomedical

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors.